Literature DB >> 17932422

Oct-4 is critical for survival/antiapoptosis of murine embryonic stem cells subjected to stress: effects associated with Stat3/survivin.

Ying Guo1, Charlie Mantel, Robert A Hromas, Hal E Broxmeyer.   

Abstract

Understanding survival/antiapoptosis of murine embryonic stem (ES) cells may enhance their clinical potential. We hypothesized that Oct-4 might be involved in survival of undifferentiated ES cells under stress. The Oct-4 tetracycline conditional knockout cell line ZHBtc4 was used to test this possibility, and apoptosis was induced by either etoposide, heat shock, or UV exposure. Apoptosis in Oct-4 knocked-down ES cells was significantly increased in response to all stress situations compared with parental cells. Oct-4 knockdown was not associated with changes in morphology or expression of Nanog, SSEA-1, KLF-4, or Sox2 within the time frame and culture conditions used, suggesting that enhanced sensitivity of these cells to apoptosis was not due to an overtly differentiated state of the cells. To address potential intracellular mediators, we focused on the inhibitor of apoptosis proteins family member Survivin, an antiapoptosis protein. The Survivin promoter was transfected into ES cells after knockdown of Oct-4. Survivin promoter activity was dramatically decreased in the Oct-4 knockdown cells. Western blots substantiated that Oct-4 knockdown ES cells had decreased Survivin protein expression. Since the Survivin promoter does not have binding sites for Oct-4, this suggested an indirect effect of Oct-4 on expression of Survivin. Leukemia inhibitory factor-induced signal transducer and activator of transcription-3 (STAT3) is responsible for ES cell survival, and STAT3 regulates Survivin expression in breast cancer cells. Western blot analysis showed that downregulated Oct-4 was associated with decreased phosphorylation of STAT3. Our results suggest that Oct-4 is essential for antiapoptosis of ES cells in response to stress, effects that may be mediated through the STAT3/Survivin pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17932422      PMCID: PMC2818886          DOI: 10.1634/stemcells.2007-0401

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  26 in total

1.  Transcriptional analysis of human survivin gene expression.

Authors:  F Li; D C Altieri
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

2.  Crystallization of redox-insensitive Oct1 POU domain with different DNA-response elements.

Authors:  A Reményi; E Pohl; H R Schöler; M Wilmanns
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2001-10-25

3.  Differential dimer activities of the transcription factor Oct-1 by DNA-induced interface swapping.

Authors:  A Reményi; A Tomilin; E Pohl; K Lins; A Philippsen; R Reinbold; H R Schöler; M Wilmanns
Journal:  Mol Cell       Date:  2001-09       Impact factor: 17.970

Review 4.  Multilineage differentiation from human embryonic stem cell lines.

Authors:  J S Odorico; D S Kaufman; J A Thomson
Journal:  Stem Cells       Date:  2001       Impact factor: 6.277

Review 5.  Validating survivin as a cancer therapeutic target.

Authors:  Dario C Altieri
Journal:  Nat Rev Cancer       Date:  2003-01       Impact factor: 60.716

6.  The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium.

Authors:  T C Doetschman; H Eistetter; M Katz; W Schmidt; R Kemler
Journal:  J Embryol Exp Morphol       Date:  1985-06

7.  New type of POU domain in germ line-specific protein Oct-4.

Authors:  H R Schöler; S Ruppert; N Suzuki; K Chowdhury; P Gruss
Journal:  Nature       Date:  1990-03-29       Impact factor: 49.962

8.  STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells.

Authors:  Naoki Kanda; Hiroshi Seno; Yoshitaka Konda; Hiroyuki Marusawa; Masashi Kanai; Toshio Nakajima; Tomoko Kawashima; Apichart Nanakin; Tateo Sawabu; Yoshito Uenoyama; Akira Sekikawa; Mayumi Kawada; Katsumasa Suzuki; Takahisa Kayahara; Hirokazu Fukui; Mitsutaka Sawada; Tsutomu Chiba
Journal:  Oncogene       Date:  2004-06-17       Impact factor: 9.867

9.  Checkpoint-apoptosis uncoupling in human and mouse embryonic stem cells: a source of karyotpic instability.

Authors:  Charlie Mantel; Ying Guo; Man Ryul Lee; Min-Kyoung Kim; Myung-Kwan Han; Hirohiko Shibayama; Seiji Fukuda; Mervin C Yoder; Louis M Pelus; Kye-Seong Kim; Hal E Broxmeyer
Journal:  Blood       Date:  2007-02-08       Impact factor: 22.113

10.  Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma.

Authors:  Yoshiyasu Aoki; Gerald M Feldman; Giovanna Tosato
Journal:  Blood       Date:  2002-10-03       Impact factor: 22.113

View more
  43 in total

1.  5-Aminoimidazole-4-carboxyamide ribonucleoside induces G(1)/S arrest and Nanog downregulation via p53 and enhances erythroid differentiation.

Authors:  Hee-Don Chae; Man-Ryul Lee; Hal E Broxmeyer
Journal:  Stem Cells       Date:  2012-02       Impact factor: 6.277

2.  Zap70 functions to maintain stemness of mouse embryonic stem cells by negatively regulating Jak1/Stat3/c-Myc signaling.

Authors:  Young Cha; Bo-hyun Moon; Mi-ok Lee; Hee-jin Ahn; Hye-jin Lee; Kyung-ah Lee; Albert J Fornace; Kwang-soo Kim; Hyuk-jin Cha; Kyung-soon Park
Journal:  Stem Cells       Date:  2010-09       Impact factor: 6.277

3.  Treatment of agarose-agarose RENCA macrobeads with docetaxel selects for OCT4(+) cells with tumor-initiating capability.

Authors:  Lawrence S Gazda; Prithy C Martis; Melissa A Laramore; Melissa A Bautista; Atira Dudley; Horatiu V Vinerean; Barry H Smith
Journal:  Cancer Biol Ther       Date:  2013-09-12       Impact factor: 4.742

4.  Power of the eternal youth: Nanog expression in the gestational choriocarcinoma.

Authors:  Ie-Ming Shih; Kuan-Ting Kuo
Journal:  Am J Pathol       Date:  2008-08-28       Impact factor: 4.307

5.  Cell growth arrest and apoptosis induced by Oct4 or Nanog knockdown in mouse embryonic stem cells: a possible role of Trp53.

Authors:  Tianji Chen; Juan Du; Guangxiu Lu
Journal:  Mol Biol Rep       Date:  2011-06-26       Impact factor: 2.316

6.  Inhibiting HDAC for human hematopoietic stem cell expansion.

Authors:  Hal E Broxmeyer
Journal:  J Clin Invest       Date:  2014-04-24       Impact factor: 14.808

7.  Commonly used fertility drugs, a diet supplement, and stress force AMPK-dependent block of stemness and development in cultured mammalian embryos.

Authors:  Alan Bolnick; Mohammed Abdulhasan; Brian Kilburn; Yufen Xie; Mindie Howard; Paul Andresen; Alexandra M Shamir; Jing Dai; Elizabeth E Puscheck; Daniel A Rappolee
Journal:  J Assist Reprod Genet       Date:  2016-05-26       Impact factor: 3.412

8.  Pancreatic cancer cells resistant to chemoradiotherapy rich in "stem-cell-like" tumor cells.

Authors:  Zhiyong Du; Renyi Qin; Cuifeng Wei; Min Wang; Chengjian Shi; Rui Tian; Chenghong Peng
Journal:  Dig Dis Sci       Date:  2010-08-04       Impact factor: 3.199

9.  Selective proapoptotic activity of polyphenols from red wine on teratocarcinoma cell, a model of cancer stem-like cell.

Authors:  Tanveer Sharif; Cyril Auger; Christian Bronner; Mahmoud Alhosin; Thibaut Klein; Nelly Etienne-Selloum; Valérie B Schini-Kerth; Guy Fuhrmann
Journal:  Invest New Drugs       Date:  2009-11-27       Impact factor: 3.850

10.  Developmental competence and expression profile of genes in buffalo (Bubalus bubalis) oocytes and embryos collected under different environmental stress.

Authors:  E M Sadeesh; P Sikka; A K Balhara; S Balhara
Journal:  Cytotechnology       Date:  2016-09-20       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.